Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review

BACKGROUND: Acute anterior uveitis (AAU) affects up to 40% of patients with axial spondyloarthritis (axSpA). An effective treatment for patients with axSpA that reduces the risk of AAU flares while also targeting axial symptoms is therefore highly desirable. Tumor necrosis factor inhibitors (TNFis)...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Horst-Bruinsma, Irene E., Robinson, Philip C., Favalli, Ennio G., Verbraak, Frank D., Kim, Mindy, Kumke, Thomas, Bauer, Lars, Hoepken, Bengt, Deodhar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562975/
https://www.ncbi.nlm.nih.gov/pubmed/36178585
http://dx.doi.org/10.1007/s40744-022-00486-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562975/
https://www.ncbi.nlm.nih.gov/pubmed/36178585
http://dx.doi.org/10.1007/s40744-022-00486-1

Ejemplares similares